|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn932060757 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
150706s2015 ne ob 001 0 eng d |
040 |
|
|
|a NLE
|b eng
|e rda
|e pn
|c NLE
|d OCLCO
|d EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d AU@
|d OCLCQ
|d CUY
|d ZCU
|d ICG
|d DKC
|d OCLCQ
|d UKMGB
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|
015 |
|
|
|a GBB595484
|2 bnb
|
016 |
7 |
|
|a 017445881
|2 Uk
|
019 |
|
|
|a 927490178
|
020 |
|
|
|a 9780128006276
|q (PDF ebook)
|
020 |
|
|
|a 0128006277
|q (PDF ebook)
|
020 |
|
|
|z 9780128005712
|q (hbk.)
|
029 |
1 |
|
|a UKMGB
|b 017445881
|
035 |
|
|
|a (OCoLC)932060757
|z (OCoLC)927490178
|
037 |
|
|
|a 9780128006276
|b Ingram Content Group
|
050 |
|
4 |
|a QP88.2 ǂb O884 2016eb
|
082 |
0 |
4 |
|a 616.7079
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Osteoimmunology :
|b interactions of the immune and skeletal systems /
|c edited by Joseph Lorenzo, Mark Horowitz, Yongwon Choi, Hiroshi Takayanagi and Georg Schett.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2015.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a CIP data; item not viewed.
|
505 |
0 |
|
|a Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Preface -- Chapter 1 -- Overview: The Developing Field of Osteoimmunology -- References -- Chapter 2 -- The Origins of the Osteoclast -- First descriptions of the osteoclast -- Early controversies: are osteoclasts capable of bone resorption? -- Early controversies: hematopoietic or mesenchymal origin of the osteoclast? -- Osteoclast: a hematopoietic cell -- Osteoclasts: cells of the myeloid lineage -- Advancing the field: culturing osteoclasts in vitro -- Identification of RANKL and OPG -- Defining osteoclast precursors within myeloid cell development -- Heterogeneity among osteoclasts -- Origins of the osteoclast through the lens of evolution -- Osteoclast-Like Activity in Invertebrates -- Osteoclasts in Fish -- Conclusions -- Acknowledgments -- References -- Chapter 3 -- Trafficking of Osteoclast Precursors -- Introduction -- A century-long search for the identity of osteoclast precursors -- Intravital two-photon imaging of bone tissues -- Osteoclast precursors are motile and circulate throughout the body -- Guidance cues sensed by osteoclast precursors in bone marrow -- S1P-dependent migratory control of osteoclast precursors -- Differences between osteoclast precursor and mature osteoclast migration mechanisms -- Control of osteoclast migration and function by Rho GTPases -- Role of integrins in osteoclast precursor migration -- Control of osteoclast precursor differentiation by GPCR-mediated inhibition of cell migration -- Unanswered questions in osteoclast precursor trafficking and differentiation -- References -- Chapter 4 -- Osteoclast Biology: Regulation of Formation and Function -- Introduction -- RANKL and RANK: an osteoclastogenic cytokine and its receptor -- TRAF6: the multifunctional signaling molecule activated by RANK.
|
505 |
8 |
|
|a What happens downstream of TRAF6? -- The role of NF-kB in osteoclast differentiation -- The critical role of AP-1 transcription factors -- MAPKs activated by RANKL -- NFATc1 is a master transcription factor of osteoclast differentiation -- Autoamplification of NFATc1 and its epigenetic regulation -- Inhibition of NFATc1 induction -- Transcriptional control governed by NFATc1 -- Costimulatory receptor signals for RANK: FcRg and DAP12 -- The ligands for the costimulatory receptors -- Importance of ITAM costimulatory signals in humans: Nasu-Hakola disease -- Additional costimulatory signals involved in osteoclastogenesis -- Receptors signaling through DAP12 -- The inhibitory signals for costimulatory signals -- Src family kinases: activation of ITAM signaling -- Syk kinase: downstream of DAP12/FcRg? -- PLCg2: enzyme and adaptor molecule -- Tec kinases: integrating RANK and ITAM signaling -- Negative regulatory role of DAP12 -- M-CSF and c-Fms: a road to proliferation and survival -- M-CSF signaling -- Erk, PI3K, and c-Fos signaling -- The osteoclast's job: bone resorption -- Osteoclast cytoskeleton: the podosomes and the sealing zone -- Osteoclast cytoskeleton: the microtubules and the sealing zone -- Osteoclast functional structure: the ruffled border -- Osteoclast and bone matrix: role of ÜvÝ3 integrin -- Integrin-associated proteins -- M-CSF and the osteoclast cytoskeleton -- Coupling factors released in osteoclastic bone resorption -- Stimulation of bone formation by clastokines -- Inhibition of bone formation by clastokines -- Coupling by cell-cell interaction between osteoclasts and osteoblasts -- Conclusions -- References -- Chapter 5 -- Osteoimmunology and the Osteoblast -- Advantages of immune-osteoblast interaction -- Immune-osteoblast interaction in fracture repair -- Immune Cells Set the Order and Tempo of Fracture Repair.
|
505 |
8 |
|
|a Dual role for TNF-Ü -- TNF is an inhibitor of Wnt signaling -- Coupling of skeletal homeostasis with innate and acquired immunity -- Normal Bone Remodeling -- Osteoblast support of hematopoiesis -- Osteoblast support of B cell differentiation -- Osteoblasts support hematopoietic stem cells -- Conclusions -- References -- Chapter 6 -- The Variety of Osteocyte Function -- Introduction -- The osteocyte network -- New tools to study osteocyte function -- Osteocytes and bone remodeling -- Osteocytes and mineral homeostasis -- Osteocytes as mechanosensors -- Osteocytes and hematopoiesis -- Conclusions -- References -- Chapter 7 -- Bone Marrow Hematopoietic Niches -- Introduction -- Hematopoiesis occurs within the bone marrow and is closely linked to skeletal development -- A role for the osteoblast lineage in supporting hematopoietic stem cells -- A perivascular niche for HSCs involves mesenchymal progenitors -- Signaling pathways implicated in microenvironment-HSC communication -- CXCL12/CXCR4 -- SCF -- Angiopoietin-1/Tie2 -- Thrombopoietin/Mpl -- Osteopontin -- Calcium-Sensing Receptor -- N-Cadherin -- Parathyroid Hormone Receptor Signaling -- Notch Signaling -- Wnt Signaling -- Prostaglandin E2 -- TGFÝ1 -- Perivascular osteoblast precursors support hematopoiesis -- Other components of the hematopoietic niche -- Macrophages -- Endothelial Cells -- Sympathetic Neurons -- Adipocytes -- Clinical implications -- HSC Engraftment After Transplantation -- Microenvironment and Disease -- Effect of Aging-Related Bone Loss on Hematopoiesis -- The bone marrow HSC microenvironment is complex -- References -- Chapter 8 -- RANK and RANKL of Bones, T Cells, and the Mammary Glands -- RANK and RANKL in bone -- Downstream signaling of RANK/RANKL -- Rank/Rankl mutations in human patients -- Osteoimmunology -- RANK and RANKL in the organogenesis of the immune system.
|
505 |
8 |
|
|a Immunotolerance -- RANK/RANKL and metastases -- RANK/RANKL and the mammary gland -- RANK and RANKL and their function in mammary stem cell biology -- Breast cancer -- Is there even more? -- Denosumab, a rational treatment for bone loss -- Conclusions -- References -- Chapter 9 -- The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells -- Receptor activator of nuclear factor-kB ligand (RANKL), receptor activator of nuclear factor-kB (RANK) and osteoprotegerin ... -- Colony-stimulating factor-1 -- Additional colony stimulating factors -- Interleukin-1 -- Tumor necrosis factor -- Additional TNF superfamily members -- Fas-Ligand -- TNF-Related Apoptosis Inducing Ligand (TRAIL) -- CD40-ligand -- Interleukin-6 -- Additional interleukin-6 family members -- Interleukin-11 -- Leukemia Inhibitory Factor -- Oncostatin M -- Interleukin-7 -- Interleukin-8 and other chemokines -- Interleukin-8 -- CCL2 -- CCL3 -- CCL9 -- CXCL12 and CXCR4 -- CX3CR1 -- CCR1 -- CCR2 -- Interleukin-10 -- Interleukin 12 -- Interleukin 15 -- Interleukin 17, Interleukin 23, and Interleukin 27 -- Interleukin 18 and interleukin 33 -- Interferons -- Additional cytokine -- Conclusions -- References -- Chapter 10 -- Coupling: The Influences of Immune and Bone Cells -- Introduction: bone remodeling and the concept of coupling -- Modeling and remodeling in anabolic therapy for the skeleton -- Osteoclast-derived factors that promote osteoblast differentiation -- Matrix-Derived Signals Released During Resorption -- Factors Secreted by the Osteoclast That Promote Bone Formation -- Do Macrophages Also Stimulate Bone Formation in the BMU? -- Other Contributions of Macrophages to Bone Formation in Remodeling -- Proteins Expressed on the Osteoclast Cell Membrane That Stimulate Osteoblast Differentiation.
|
520 |
|
|
|a Of Section II: Multiple Cell Types Promote Bone Formation During the Remodeling Process -- What is the target cell of osteoclast-derived factors that may promote bone formation? -- How do osteocytes contribute to coupling? -- Promotion of bone formation in the BMU during the reversal phase -- The influences of T and B lymphocytes on the coupling process -- Signals between the bone surface and the vasculature -- Isolation of the remodeling site by the bone remodeling canopy -- Conclusions -- References -- Chapter 11 - The Role of the Immune System in the Development of Osteoporosis and Fracture Risk -- Introduction -- Connections between bone and the immune system -- Bone remodeling -- Periarticular bone structure and bone loss in inflammatory arthritis -- Bone involvement in rheumatic diseases -- Bone Changes in Rheumatic Diseases -- Bone Erosions -- Bone Marrow Edema (BME) -- Local Peri-Inflammatory Bone Changes -- Generalized Bone Changes -- Fracture Healing -- Methods for quantifying changes in bone in inflammatory rheumatic diseases -- CR -- High-resolution CR -- Radiogrammetry and DXR -- Photonabsorptiometry -- Magnetic resonance imaging (MRI) -- Quantitative ultrasound (QUS) of the bone -- Musculoskeletal ultrasound (MSUS) -- Quantitative computed tomography (QCT) -- High resolution peripheral quantitative computed tomography (HRpQCT) -- Bone and inflammation markers -- Clinical risk factors for low BMD, falls, and fractures -- From fracture risk evaluation to fracture prevention: a 5-step plan -- Case Finding -- Risk Evaluation -- Clinical Risk Factors -- Measurements and Imaging Tools -- Biomarkers -- Risk of falls in RA -- Differential diagnosis -- Fracture prevention in inflammatory joint diseases -- General Measures -- Calcium and Vitamin D -- Treatment of Glucocorticoid Osteoporosis.
|
504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Musculoskeletal system
|x Immunology.
|
650 |
|
6 |
|a Appareil locomoteur
|x Immunologie.
|
700 |
1 |
|
|a Lorenzo, Joseph,
|e editor.
|
700 |
1 |
|
|a Horowitz, Mark,
|e editor.
|
700 |
1 |
|
|a Choi, Yongwon,
|e editor.
|
700 |
1 |
|
|a Takayanagi, Hiroshi,
|e editor.
|
700 |
1 |
|
|a Schett, Georg,
|e editor.
|
758 |
|
|
|i has work:
|a Osteoimmunology (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYqxVt3TtVbJcDhbKtJrTw
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version
|z 9780128005712
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4003868
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4003868
|
994 |
|
|
|a 92
|b IZTAP
|